1. Alagawany M, El-Hack M, Farag MR, Tiwari R, Dhama K. Biological effects and modes of action of carvacrol in animal and poultry pro-duction and health-a review. Adv Anim Vet Sci 2015; 3(2): 73-84.

2. Melo FHC, Moura BA, de Sousa DP, de Vasconcelos SMM, Macedo DS, Fonteles MMdF, et al. Antidepressant‐like effect of carvacrol (5‐Isopropyl‐2‐methylphenol) in mice: involvement of dopaminergic system. Fundam Clin Pharmacol 2011; 25(3): 362-7.

3. Sharifi‐Rad M, Varoni EM, Iriti M, Martorell M, Setzer WN, del Mar Contreras M, et al. Carvacrol and human health: A comprehensive review. Phytother Res 2018; 32(9): 1675-87.

4. Arunasree K. Anti-proliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB 231. Phytomedicine 2010; 17(8-9): 581-8.

5. Garcia C, Talarico L, Almeida N, Colombres S, Duschatzky C, Damonte E. Virucidal activity of essential oils from aromatic plants of San Luis, Argentina. Phytother Res 2003; 17(9): 1073-1075.

6. Trabace L, Zotti M, Morgese MG, Tucci P, Colaianna M, Schiavone S, et al. Estrous cycle affects the neurochemical and neurobehavioral profile of carvacrol-treated female rats. Toxicol Appl Pharmacol 2011; 255(2): 169-175.

7. Ozer EK, Goktas MT, Toker A, Bariskaner H, Ugurluoglu C, Iskit AB. Effects of carvacrol on survival, mesenteric blood flow, aortic function and multiple organ injury in a murine model of polymicrobial sepsis. Inflammation 2017; 40: 1654-63.

8. Khazdair MR, Ghorani V, Alavinezhad A, Boskabady MH. Pharmacological effects of Zataria multiflora Boiss L. and its constituents focus on their anti‐inflammatory, antioxidant, and immunomodulatory effects. Fundam Clin Pharmacol 2018; 32(1): 26-50.

9. Hussein J, El-Banna M, Mahmoud KF, Morsy S, Latif YA, Medhat D, et al. The therapeutic effect of nano-encapsulated and nano-emulsion forms of carvacrol on experimental liver fibrosis. Biomed Pharmacother 2017; 90: 880-7.

10. Mortazavi A, Kargar HMP, Beheshti F, Anaeigoudari A, Vaezi G, Hosseini M. The effects of carvacrol on oxidative stress, inflammation, and liver function indicators in a systemic inflammation model induced by lipopolysaccharide in rats. Int J Vitam Nutr Res 2023; 93(2): 111-21.

11. Zhao W, Chen L, Zhou H, Deng C, Han Q, Chen Y, et al. Protective effect of carvacrol on liver injury in type 2 diabetic db/db mice. Mol Med Rep 2021; 24(5): 1-11.

12. Mohseni R, Karimi J, Tavilani H, Khodadadi I, Hashemnia M. Carvacrol ameliorates the progression of liver fibrosis through targeting of Hippo and TGF-β signaling pathways in carbon tetrachloride (CCl4)-induced liver fibrosis in rats. Immunopharmacol Immunotoxicol 2019; 41(1): 163-171.

13. Naganthran A, Verasoundarapandian G, Khalid FE, Masarudin MJ, Zulkharnain A, Nawawi NM, et al. Synthesis, Characterization and Biomedical Application of Silver Nanoparticles. Materials 2022; 15(2): 427.

14. Xu L, Wang Y-Y, Huang J, Chen C-Y, Wang Z-X, Xie H. Silver nanoparticles: Synthesis, medical applications and biosafety. Theranostics 2020; 10(20): 8996.

15. Wang ZX, Chen CY, Wang Y, Li FXZ, Huang J, Luo ZW, et al. Ångstrom‐Scale Silver Particles as a Promising Agent for Low‐Toxicity Broad‐Spectrum Potent Anticancer Therapy. Adv Funct Mater 2019; 29(23): 1808556.

16. Dziedzic A, Kubina R, Bułdak RJ, Skonieczna M, Cholewa K. Silver nanoparticles exhibit the dose-dependent anti-proliferative effect against human squamous carcinoma cells attenuated in the presence of berberine. Molecules 2016; 21(3): 365.

17. Xu L, Shao A, Zhao Y, Wang Z, Zhang C, Sun Y, et al. Neurotoxicity of silver nanoparticles in rat brain after intragastric exposure. J Nanosci Nanotechnol 2015; 15(6): 4215-23.

18. Miethling-Graff R, Rumpker R, Richter M, Verano-Braga T, Kjeldsen F, Brewer J, et al. Exposure to silver nanoparticles induces size-and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells. Toxicol In Vitro 2014; 28(7): 1280-9.

19. Ong C, Lee Q, Cai Y, Liu X, Ding J, Yung L, et al. Silver nanoparticles disrupt germline stem cell maintenance in the Drosophila testis. . Sci Rep 2016; 6: 20632.

20. Gaiser BK, Hirn S, Kermanizadeh A, Kanase N, Fytianos K, Wenk A, et al. Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol Sci 2013; 131(2): 537-47.

21. Liu J, Sonshine DA, Shervani S, Hurt RH. Controlled release of biologically active silver from nanosilver surfaces. ACS nano 2010; 4(11): 6903-13.

22. Wilhelm EA, Jesse CR, Roman SS, Nogueira CW, Savegnago L. Hepatoprotective effect of 3-alkynyl selenophene on acute liver injury induced by D-galactosamine and lipopolysaccharide. Exp Mol Pathol 2009; 87(1): 20-6.

23. Wong KH, Nam HY, Lew SY, Naidu M, David P, Kamalden TA, et al. Discovering the Potential of Natural Antioxidants in Age-Related Macular Degeneration: A Review. Pharmaceuticals 2022; 15(1): 101.

24. Powers SK, Jackson MJ. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev 2008; 88(4): 1243-76.

25. Hsseinigouzdagani M, Geyikoglu F, Çolak S, Türkez H, Bakir TO, Bakir M. The Efficacy of Carvacrol on Renal Damage in Rats with Acute Pancreatitis. J Essent Oil-Bear Plants 2014; 17(5): 847-58.

26. Shariatzadeh MA, Maleki P. Evaluation of the protective effect of Nigella sativa oil on liver in NMRI male mice following silver nanoparticles toxicity. J Anim Res 2020; 33(3): 252-64. [in Persian].

27. Bakır M, Geyikoglu F, Colak S, Turkez H, Bakır TO, Hosseinigouzdagani M. The carvacrol ameliorates acute pancreatitis-induced liver injury via antioxidant response. Cytotechnology 2016; 68(4): 1131-46.

28. Noorafshan A, Esmail-Zadeh B, Bahmanpour S, Poost-Pasand A. Early stereological changes in liver of Sprague-Dawley rats after streptozotocin injection. Indian J Gastroenterol 2005; 24(3): 104.

29. Moezi L, Arshadi SS, Motazedian T, Seradj SH, Dehghani F. Anti-diabetic effects of amygdalus lycioides spach in streptozocin-induced diabetic rats. Iran J Pharm Res 2018; 17(1): 353-64.

30. Hoseini L, Roozbeh J, Sagheb M, Karbalay-Doust S, Noorafshan A. Nandrolone decanoate increases the volume but not the length of the proximal and distal convoluted tubules of the mouse kidney. Micron 2009; 40(2): 226-30.

31. Nyengaard JR. Stereologic methods and their application in kidney research. J Am Soc Nephrol 1999; 10(5): 1100-23.

32. Mehranjani MS, Noorafshan A, Momeni H, Abnosi M, Mahmoodi M, Anvari M, et al. Stereological study of the effects of vitamin E on testis structure in rats treated with para-nonylphenol. Asian J Androl 2009; 11(4): 508-16.

33. Mayerhöfer TG, Mutschke H, Popp J. Employing theories far beyond their limits—the case of the (Boguer‐) beer–lambert law. Chem Phys Chem 2016; 17(13): 1948-55.

34. Faedmaleki F, Shirazi FH, Salarian A-A, Ashtiani HA, Rastegar H. Toxicity effect of silver nanoparticles on mice liver primary cell culture and HepG2 cell line. Iran J Pharm Res 2014; 13(1): 235-42.

35. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 2008; 20(6): 575-83.

36. Rashno M, Fatemi Tabatabaei SR, Khaksary Mahabady M, Ghaderi S. Maternal exposure to silver nanoparticles in mice: effects on dams’ reproductive performance and pups’ neurobehavioral ontogeny. Anat Sci J 2014; 11(1): 41-52.

37. Yu WJ, Son JM, Lee J, Kim SH, Lee IC, Baek HS, et al. Effects of silver nanoparticles on pregnant dams and embryo-fetal development in rats. Nanotoxicology 2014; 8(sup1): 85-91.

38. Najjaran A, Moghaddam NA, Zarchi SR, Mohsenifar J, Rasoolzadeh R. Toxicity effects of nanosilver on liver enzymes, liver and lung tissues. Int J Biol Biomed Eng 2014; 1(1): 11-5.

39. Heydarnejad MS, Yarmohammadi-Samani P, Mobini Dehkordi M, Shadkhast M, Rahnama S. Histopathological effects of nanosilver (Ag-NPs) in liver after dermal exposure during wound healing. Nanomed J 2014; 1(3): 191-7.

40. Loghman A, Iraj SH, Naghi DA, Pejman M. Histopathologic and apoptotic effect of nanosilver in liver of broiler chickens. Afr J Biotechnol 2012; 11(22): 6207-11.

41. Heydrnejad MS, Samani RJ, Aghaeivanda S. Toxic effects of silver nanoparticles on liver and some hematological parameters in male and female mice (Mus musculus). Biol Trace Elem Res 2015; 165(2): 153-8.

42. Jafarzadeh R. A survey ofacute histopathological effects of silver nanoparticles on liver, kidney with blood cells during oral administration in male mice (Mus musculus. J Shahrekord Univ Med Sci 2015; 17(4): 97-107.

43. Gopinath P, Gogoi SK, Chattopadhyay A, Ghosh SS. Implications of silver nanoparticle induced cell apoptosis for in vitro gene therapy. Nanotechnology 2008; 19(7): 075104.

44. Naguib M, Mahmoud UM, Mekkawy IA, Sayed AE-DH. Hepatotoxic effects of silver nanoparticles on Clarias gariepinus; Biochemical, histopathological, and histochemical studies. Toxicol Rep 2020; 7: 133-41.

45. Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014; 2014.

46. Arora S, Jain J, Rajwade J, Paknikar K. Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol Lett 2008; 179(2): 93-100.

47. Yavari M, Talebi A, Rezaie Zarchi SRS, SAR. Effects of Different Doses of Silver Nanoparticles on Sperm Parameters, Chromatin Structure and DNA Integrity in Mice. J Cell Tissue 2015; 6(2): 177-85. [in Persian]

48. Samarghandian S, Farkhondeh T, Samini F, Borji A. Protective effects of carvacrol against oxidative stress induced by chronic stress in rat’s brain, liver, and kidney. Biochem Res Int 2016; 2016: 2645237.

49. Canbek M, Uyanoglu M, Bayramoglu G, Senturk H, Erkasap N, Koken T, et al. Effects of carvacrol on defects of ischemia-reperfusion in the rat liver. Phytomedicine 2008; 15(6-7): 447-52.

50. Awasthi KK, Verma R, Awasthi A, Awasthi K, Soni I, John P. In vivo genotoxic assessment of silver nanoparticles in liver cells of Swiss albino mice using comet assay. Adv Mater Lett 2015; 6(3): 187-93.